Unlocking the Economic Potential of Healthy Ageing

By Melike Belenli Gümüş

September 4, 2024

Introduction

The global demographic evolution involves significant shifts in population age structures. According to United Nations, the world’s population aged 65 and over is expected to double by 2050, while fertility rates are forecasted to decline. These changes carry extensive economic and societal implications, as seen in the correlation between population age structure and economic growth. Factors like human capital, health, and disability impact this dynamic. Health notably plays a crucial role in shaping work and consumption behaviours across the lifespan. Understanding how health influences the time older adults spend on non-market activities, such as housing, transport, nutrition, clothing, laundry services, childcare, adult care, and voluntary work can provide insights into the economic potential of healthy ageing.

The Economic Impact of Health at Older Ages

Investing in health at older ages presents a strategic economic opportunity. While economic growth has traditionally been associated with the working-age population, healthy ageing can prolong labour force participation, boost productivity, and cut healthcare costs. Furthermore, good health empowers older individuals to partake in non-market productive activities, significantly benefiting societal welfare. However, quantifying the economic gains linked to better health at older ages poses challenges.

Quantifying the Economic Value of Health

An innovative approach using time use surveys offers a fresh perspective on the economic value of healthy ageing. By examining how older individuals allocate their time based on health status, we can estimate the monetary value of health-related changes in time use. Findings indicate that good health correlates with increased engagement in non-market activities, leading to economic gains. This highlights the role of health in enabling active participation among older populations.

A recent study revealed significant differences in the time spent on non-market activities based on self-perceived health. For instance, individuals in very good health spent more time on nutrition-related activities compared to those in very bad health. Specifically, those in very bad health spent 958 fewer minutes per month on nutrition-related activities. Moreover, the study found that individuals in very good health were more likely to engage in part-time or full-time work. In contrast, less than 2% of those in fair or bad health were engaged in any paid work.

Figure 1: Distribution of predictive values of survey-weighted generalised linear models for monthly time spent (in minutes) by non-market productive activities, by age and by self-perceived health, in the United Kingdom 2014–15. Control variables: sex, marital status, employment status and education.

Economic Implications

To estimate the economic impact of health improvements, researchers calculated a scenario where 10% of individuals in very bad health shifted to very good health. This shift could result in economic gains of up to £278 million (in 2015 GBP) through the production of non-market activities. This economic gain is mainly estimated by monetising the predicted value of minutes spent in non-market productive activities, based on the hourly values of each non-market activity as shown in Figure 2. For example, in the 65-74 age group, individuals in very good health engaged in non-market productive activities for about 7,831 minutes per month, compared to only 3,983 minutes for those in very bad health. This creates a monthly difference of £439 for an average person between being in very good versus being in very bad health.

Figure 2: Hourly value of non-market productive activities in pounds sterling using the 2000 United Kingdom Household Satellite Account, converted into 2015 estimates.

Conclusion

Understanding the economic value of health at older ages is vital for crafting effective policies and interventions. By acknowledging the contributions of older individuals to society, a compelling case can be made for prioritising health investments in this demographic. Enhancing our comprehension of the intricate link between health, time use, and economic outcomes through refined approaches and objective health measures is crucial. Policymakers should consider these findings when designing health interventions aimed at older populations.

Reference url

Recent Posts

Mavyret acute hepatitis C
         

Mavyret Acute Hepatitis C: Pioneering Treatment Expansion and Economic Implications

🌟 Did you know that the FDA has just approved the first-ever treatment specifically for acute Hepatitis C?

AbbVie’s Mavyret (glecaprevir/pibrentasvir) is now set to improve the way we think about HCV interventions, enabling earlier treatment to reduce long-term complications and improve patient outcomes. This approval not only addresses an urgent public health need but also aligns with evolving healthcare delivery models focused on cost-effective solutions.

Curious to learn more about the implications of this significant advancement in hepatitis care? Review the full article for insightful analysis on the future of HCV treatment!

#SyenzaNews #HealthcareInnovation #MarketAccess #HealthEconomics

HIV vaccine trials
    

Advancements in HIV Vaccine Trials: Promising Results from mRNA Strategies

🌍 Are we finally making strides in the fight against HIV?

Recent phase 1 vaccine trials using mRNA technology have shown promising results in activating immune responses that could lead to broadly neutralizing antibodies (bnAbs). This innovative approach not only addresses HIV’s rapid mutation but also offers critical insights for high-prevalence regions.

Dive into the full article to explore how these trials could shape the future of HIV prevention and what it means for global health!

#SyenzaNews #globalhealth #HIV #clinicaltrials

EHK clusters 2026 report
       

EHK Clusters 2026 Report: Enhancements in Dutch Risk Equalization for High-Cost Pharmaceuticals

🚀 Are you curious about how the Dutch healthcare system is adapting to high-cost pharmaceuticals?

The latest EHK clusters report for 2026 brings crucial updates to the risk-equalization model, enhancing equity among health insurers while closely managing skyrocketing costs. With innovative clustering techniques and revised reimbursement figures, these changes aim to improve access and accountability in an increasingly competitive healthcare landscape.

Dive into the full article to uncover the implications for health economics and policy!

#SyenzaNews #HealthEconomics #HealthcareInnovation

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.